Navigating facilitated regulatory pathways during a disease X pandemic

In 2018, the Bill and Melinda Gates Foundation convened over thirty subject matter experts in clinical development, manufacturing, and regulatory assessment to determine how the development and approval of medical countermeasures could be accelerated in the event of Disease X. Disease X is the resul...

Descripción completa

Detalles Bibliográficos
Autores principales: Simpson, Shmona, Chakrabarti, Ajoy, Robinson, David, Chirgwin, Keith, Lumpkin, Murray
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584587/
https://www.ncbi.nlm.nih.gov/pubmed/33110630
http://dx.doi.org/10.1038/s41541-020-00249-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584587/
https://www.ncbi.nlm.nih.gov/pubmed/33110630
http://dx.doi.org/10.1038/s41541-020-00249-5

Ejemplares similares